Progressive multiple sclerosis represents a significant management challenge, so we asked three well-known researchers and clinicians to share their thoughts on the “best” treatment regimen: Stuart D. Cook, MD, of Rutgers-New Jersey Medical School in Newark; Tanuja Chitnis, MD, of Brigham and Women’s Hospital in Boston; and Robert Fox, MD, of the Cleveland Clinic’s Mellen Center for Multiple Sclerosis. They noted that drugs currently approved for relapsing-remitting MS may also hold promise for progressive disease, but a host of new treatment approaches are in the works, too.
Watch this video presentation found here:
http://www.medpagetoday.com/HOTTOPICSMultipleSclerosis/Neurology/GeneralNeurology-Videos/944
.
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY